Eric Roath, PharmD

Eric Roath, PharmD, is the Director of Professional Practice for the Michigan Pharmacists Association (MPA). He assists pharmacists and health care stakeholders on matters of pharmacy practice, including practice innovation, third-party payer concerns, and pharmacy law. He is a 2012 Doctorate of Pharmacy graduate from Ferris State University College of Pharmacy. Following graduation, he completed a postgraduate year 1 community pharmacy residency at PGPA Pharmacy and an executive fellowship with the MPA.

Articles by Eric Roath, PharmD

Lyme Vaccine Moves to Clinical Trials

ByEric Roath, PharmD

December 23rd 2016

The FDA recently approved an Investigational New Drug application submitted by Valneva SE.

Is Ecstasy Becoming a Legitimate Medical Treatment?

ByEric Roath, PharmD

December 6th 2016

A recent report in the New York Times highlights New Trials for Ecstasy as Relief for Post Traumatic Stress Disorder (PTSD) Patients. The Internet is now buzzing with chatter about how methylenedioxymethamphetamine (MDMA; also known as ecstasy) could become legal in the coming years.

Michigan Introduces Legislation Targeting Opioid Overprescribing

ByEric Roath, PharmD

November 11th 2016

On November 10, 2016, Michigan State Representatives introduced HB 6045, which would amend the Michigan Public Health Code to provide restrictions on the quantity of prescription opioid medications that can be issued by a prescriber under certain circumstances. This legislation comes on the heels of recent efforts by the CDC to raise awareness and hopefully curtail the growing opioid epidemic.

Big Developments in Biosimilars

ByEric Roath, PharmD

November 4th 2016

Biosimilars have been in the news quite a bit lately. Here’s an update on some of the big developments related to biosimilar development, approval, and regulations